The NimC1 molecule has been described as a phagocytosis receptor, and is being used as a marker for professional phagocytes, the plasmatocytes, in Drosophila melanogaster. In studies including tumor-biology, developmental biology, and cell mediated immunity, monoclonal antibodies (P1a and P1b) to the NimC1 antigen are used. As we observed that these antibodies did not react with plasmatocytes of several strains and genetic combinations, a molecular analysis was performed on the structure of the nimC1 gene. In these strains we found 2 deletions and an insertion within the nimC1 gene, which may result in the production of a truncated NimC1 protein. The NimC1 positivity was regained by recombining the mutation with a wild-type allele or by using nimC1 mutant lines under heterozygous conditions. By means of these procedures or using the recombined stock, NimC1 can be used as a marker for phagocytic cells in the majority of the possible genetic backgrounds.
Introduction
The classification of Drosophila hemocytes initially relied on morphological distinction between hemocyte types. To facilitate the identification of the different effector cell classes, an array of molecular markers was created. One of these markers is NimrodC1 (NimC1), which was identified on the surface of the Drosophila phagocytes (plasmatocytes) by the mixture of two monoclonal antibodies (P1a and P1b). 1 Functional assessment of NimC1 in plasmatocytes and S2 cells proved that it plays a role in the phagocytosis of bacteria. 1 These results were further underlined by in vitro analysis, which showed the direct binding of NimC1 to fluorescently labeled bacteria. 2 Structural investigation of the protein revealed that it contains a set of characteristic EGF-like domains (NIM domains), which can also be found in a set of proteins potentially related to phagocytosis; these proteins constitute the Nimrod protein-family. 3 In the past years, NimC1 has become the standard marker for the identification of Drosophila plasmatocytes. [4] [5] [6] [7] [8] [9] However, it was recently observed that there is a variation in the expression of the NimC1 receptor among Drosophila lines. As NimC1 is broadly used as a marker for plasmatocytes, we performed an analysis involving the nimC1 gene to find an explanation for this phenomenon.
Results and Discussion
To find out the reason for the lack of the NimC1 antigen in some stocks and genetic combinations (Fig. 1A) , we analyzed the expression of the nimC1 gene in NimC1 negative and NimC1 positive strains using RT-PCR. According to the data available on FlyBase (http://flybase.org/), 2 transcripts, nimC1-RA and nimC1-RB are annotated; therefore, we used isoform specific primer pair sets to identify the predicted transcripts. We detected both transcripts in all of the investigated lines, however, in P1 negative lines (w (Fig. 1C) . The latter deletion and the insertion are presumable results of the excision of a mobile element, which are known to leave footprints in the genome after remobilization.
The 355 bp deletion and the 5 bp insertion generate a frameshift mutation in both nimC1 transcripts. As a result of the frameshift, the insertion is followed by a newly arisen sequence of 12 codons and a UGA stop codon (Fig. 1C) . These alterations suggest that the mutant NimC1 proteins may be truncated. Instead of the normal 620 and 622 amino acid residues, the mutant NimC1 proteins are composed of only 307 and 309 amino acids in the case of the NimC1-PA and the NimC1-PB, respectively. The truncated NimC1 proteins, therefore, lack their C-terminal regions, including their intracellular and transmembrane domains, as well as four NIM repeats from the extracellular region (Fig. 1C) . As the deletions do not affect the N-terminal signal peptide, the truncated proteins of the mutant lines may be secreted to the hemolymph, and in this particular case, resemble the NimB proteins, the secreted members of the Nimrod protein family. 1, 3 As the NimC1 antigen was not detected in the hemolymph in the tested mutant lines (data not shown), the specific epitopes for the P1a and P1b monoclonal antibodies may be located on the missing protein regions. Basic genetic analysis demonstrated that the occurrence of the P1-negative phenotype is consistent with the presence of a recessive mutation on the second chromosome. Thus, when it is suspected that P1 negativity is the result of the genetic background (as in the case of progeny emerging from GAL4/UAS crosses), it is advisable to check the parental chromosomes for P1 staining. This can be done by test crossing the parental lines to known P1-negative and P1-positive lines, and checking for P1 expression in the trans-heterozygous F1 progeny. Therefore, we recommend using the nimC1 mutants in heterozygous conditions, and if unavoidable, the nimC1 mutant locus can be recombined with the black marker gene to gain a P1 positive line. For a list of confirmed P1 negative stocks, please refer to Table S2. P1-negative chromosomes harboring FRT elements for mitotic clone generation represent a special case. Mitotic clones are generated to examine the phenotypic effects of homozygous mutation of a given gene. If the P1-negative locus resides on the same arm, then the resulting FRT clones in blood cells (in the lymph gland or circulating hemocytes) will also be P1-negative, while surrounding heterozygous cells, often used as an internal experimental Supplemental Table 1 . Oligonucleotide primers used in this study.
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